openPR Logo
Press release

Pharmacogenomics Market Size & Share Expanding Across the Globe

06-17-2019 11:04 AM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
Pharmacogenomics Market

Pharmacogenomics Market

Allied Market Research published a report, titled, "Pharmacogenomics Market by Technology (Sequencing, Polymerase Chain Reaction, Gel Electrophoresis, Mass Spectrometry, Microarray, and Others), Application (Cardiovascular Diseases, Infectious Diseases, Oncology, Neurological Diseases, Psychiatry, Pain Management, and Others), and End User (Hospitals & Clinics, Research Institutions and Academic Institutes and Others): Opportunity Analysis and Industry Forecast, 2017 – 2025." The report provides a comprehensive analysis of top investment pockets, drivers & opportunities, major segments, value chain, and competitive scenario. According to the report, the global pharmacogenomics market garnered $5.3 billion in 2017, and is expected to reach $10.2 billion by 2025, registering a CAGR of 8.6% from 2018 to 2025.

Increasing demand for personalized therapy, growing prevalence of life-threatening diseases worldwide, and technological advancements in the molecular techniques used for pharmacogenomics-based diagnostics have fueled the growth of global pharmacogenomics market. On the other hand, lack of well-trained as well as technically skilled professionals and complexities in finding the right gene affecting the drug response have happened to curb the growth to some extent. However, technological advancements in molecular techniques used for pharmacogenomics diagnostic tests have created lucrative opportunities in the segment.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/5220

Polymerase chain reaction to maintain its dominance during the forecast period-
By technology, polymerase chain reaction accounted for two-fifth of the total market in 2017 and have come out as the lion shareholder. The fact that polymerase chain reaction is the one of the most commonly used technologies used during the pharmacogenomics diagnostic tests has spurred the growth. Also, its edge over other molecular diagnostic tools in amplifying the sample DNA has coaled the growth.

Oncology Segment to maintain its top status till 2025-

By application, the oncology segment contributed to more than one-third of the total market in 2017 and is anticipated to dominate by 2025. This is due to the prevalence of cancer with lack of proper drugs at disposal and chances of relapse. Pharmacogenomics is used in the development of personalized therapy which will be able to provide personalized therapy to the patients suffering from this deadly disease.

Hospitals and clinics segment to be dominant through 2018-2025-

Based on end-user, hospitals and clinics held the major share, accounting for more than two-third of the total market in 2017. This is due to the presence of technologically advanced diagnostic equipment and highly skilled health care professionals.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/5220

North America to have the major share-

Based on geography, North America contributed to two-fifth of the total market share in 2017. Higher disposable income group, better infrastructure, high-end healthcare facilities, and several government based initiatives for the welfare of the citizens have propelled the growth of pharmacogenomics market in the region.

Key players in the industry-

Leading market players analyzed in the research include Dynamic DNA Laboratories, Empire Genomics, LLC, Illumina, Inc., Thermo Fisher Scientific, Inc., Abbott Laboratories, OneOme LLC, Myriad Genetics Inc., OPKO Health, Inc. (GeneDx), and F. Hoffmann-La Roche Ltd. They have adopted a plethora of strategies to maintain their top status in the industry. The other players mentioned in the report include Bayer AG, Teva Pharmaceutical Industries Ltd., and Assurex Health Inc

Purchase This Report with Discounted Price @ https://www.alliedmarketresearch.com/checkout-final/bbadb37166ff9152791d1eac0bbf43c7

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975

help@alliedmarketresearch.com

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharmacogenomics Market Size & Share Expanding Across the Globe here

News-ID: 1777331 • Views: 237

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for Pharmacogenomics

Pharmacogenomics Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Pharmacogenomics Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 124 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/global-paediatric-sports-medicine-market_p104058.html   Pharmacogenomics is the study of the role of the
Pharmacogenomics Market Evolving Industry Trends and key Insights by 2026
​Pharmacogenomics is an essential research area for development of medication for pain, cancer, psychotropic, and cardiovascular disease. The success of this medication is possible through the use of innovative technologies that help define the dosage setting for subsets of the population and an individual’s response to a specific drug. The success of the precision medicine is possible through the application of pharmacogenomics that uses information about a person’s genes, enzyme
World Pharmacogenomics Market - Explores New Growth Opportunities By 2023
Pharmacogenomics defines how genes can affect a person’s response to drugs. Pharmacogenomics is predicted to treat a wide range of health problems including cardiovascular diseases, Alzheimer disease, cancer, HIV/AIDS, and asthma, in near future. The growing biotech industry boosts the market growth. According to the Organization for Economic Co-operation and Development in 2017, biotech R&D in the business enterprise sector was 11.3%, and 9.4% of total business enterprise R&D, for
Pharmacogenomics Market Technological Advancements will Allow Overcoming Challen …
Pharmacogenomics deals with the study of inherited variations in human genes that affect an individual’s reaction to a particular drug. It co-integrates the genetic sciences with pharmaceutical science. Thus, it is the science of individualizing the drug, which is based on individual’s genetic makeup. And, many times pharmacogenomics are linked to personalized medicine, as the environmental conditions, genetic variations, and changing lifestyle greatly influence the type and severity of diseases
Pharmacogenomics Market Analysis, Forecast, and Assessment 2025
Pharmacogenomics is the study of inherited variations in human genes that affect an individual’s reaction to a particular drug. It co-integrates genetic science with pharmaceutical science. Hence, it is the science of individualizing a drug based on an individual’s genetic makeup. Pharmacogenomics is also linked to personalized medicine, as environmental conditions, genetic variations, and changing lifestyle greatly influence the type and severity of diseases as well as therapeutic responses that
Pharmacogenomics Market : New Study Offers Insights for 2017 - 2025
Pharmacogenomics is the study of inherited variations in human genes that affect an individual’s reaction to a particular drug. It co-integrates genetic science with pharmaceutical science. Hence, it is the science of individualizing a drug based on an individual’s genetic makeup. Pharmacogenomics is also linked to personalized medicine, as environmental conditions, genetic variations, and changing lifestyle greatly influence the type and severity of diseases as well as therapeutic responses that